These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 39062515)

  • 21. Detection of glioblastoma in biofluids.
    Figueroa JM; Carter BS
    J Neurosurg; 2018 Aug; 129(2):334-340. PubMed ID: 29053069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumor DNA from Cerebrospinal Fluid.
    Martínez-Ricarte F; Mayor R; Martínez-Sáez E; Rubio-Pérez C; Pineda E; Cordero E; Cicuéndez M; Poca MA; López-Bigas N; Ramon Y Cajal S; Vieito M; Carles J; Tabernero J; Vivancos A; Gallego S; Graus F; Sahuquillo J; Seoane J
    Clin Cancer Res; 2018 Jun; 24(12):2812-2819. PubMed ID: 29615461
    [No Abstract]   [Full Text] [Related]  

  • 23. Cerebrospinal fluid biomarkers of malignancies located in the central nervous system.
    Verheul C; Kleijn A; Lamfers MLM
    Handb Clin Neurol; 2017; 146():139-169. PubMed ID: 29110768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Establishment of diagnostic model of cerebrospinal protein fingerprint pattern for glioma and its clinical application].
    Liu J; Zheng S; Yu JK; Yu XB; Liu WG; Zhang JM; Hu X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 34(2):141-7. PubMed ID: 15812888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GC/MS-based metabolomic analysis of cerebrospinal fluid (CSF) from glioma patients.
    Nakamizo S; Sasayama T; Shinohara M; Irino Y; Nishiumi S; Nishihara M; Tanaka H; Tanaka K; Mizukawa K; Itoh T; Taniguchi M; Hosoda K; Yoshida M; Kohmura E
    J Neurooncol; 2013 May; 113(1):65-74. PubMed ID: 23456655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult Gliomas.
    Valerius AR; Webb MJ; Hammad N; Sener U; Malani R
    Curr Oncol Rep; 2024 Apr; 26(4):377-390. PubMed ID: 38488990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New Frontiers in Diagnosis and Therapy of Circulating Tumor Markers in Cerebrospinal Fluid In Vitro and In Vivo.
    Sindeeva OA; Verkhovskii RA; Sarimollaoglu M; Afanaseva GA; Fedonnikov AS; Osintsev EY; Kurochkina EN; Gorin DA; Deyev SM; Zharov VP; Galanzha EI
    Cells; 2019 Oct; 8(10):. PubMed ID: 31581745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating Biomarkers for Glioma: A Review.
    Jones J; Nguyen H; Drummond K; Morokoff A
    Neurosurgery; 2021 Feb; 88(3):E221-E230. PubMed ID: 33442748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liquid biomarkers in glioma.
    Tamai S; Ichinose T; Nakada M
    Brain Tumor Pathol; 2023 Apr; 40(2):66-77. PubMed ID: 36800124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of free DNA quantification in serum and cerebrospinal fluid in glioma patients.
    Shi W; Lv C; Qi J; Zhao W; Wu X; Jing R; Wu X; Ju S; Chen J
    J Mol Neurosci; 2012 Mar; 46(3):470-5. PubMed ID: 21881830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS Malignancies.
    Shalaby T; Grotzer MA
    Int J Mol Sci; 2015 Dec; 16(12):29103-19. PubMed ID: 26690130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Circulating microrPas as new potential biomarkers for the diagnosis of high-grade gliomas].
    Gareev IF; Novicova LB; Beylerli OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(5):86-90. PubMed ID: 31317895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liquid biopsies for diagnosing and monitoring primary tumors of the central nervous system.
    Le Rhun E; Seoane J; Salzet M; Soffietti R; Weller M
    Cancer Lett; 2020 Jun; 480():24-28. PubMed ID: 32229189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNA.
    Pan C; Diplas BH; Chen X; Wu Y; Xiao X; Jiang L; Geng Y; Xu C; Sun Y; Zhang P; Wu W; Wang Y; Wu Z; Zhang J; Jiao Y; Yan H; Zhang L
    Acta Neuropathol; 2019 Feb; 137(2):297-306. PubMed ID: 30460397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liquid Biopsy in Primary Brain Tumors: Looking for Stardust!
    Fontanilles M; Duran-Peña A; Idbaih A
    Curr Neurol Neurosci Rep; 2018 Mar; 18(3):13. PubMed ID: 29520561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ExRNA in Biofluids as Biomarkers for Brain Tumors.
    Rennert RC; Hochberg FH; Carter BS
    Cell Mol Neurobiol; 2016 Apr; 36(3):353-60. PubMed ID: 26993514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating MicroRNAs as Potential Biomarkers in Glioma: A Mini-Review.
    Choppavarapu L; Kandi SM
    Endocr Metab Immune Disord Drug Targets; 2021; 21(2):195-202. PubMed ID: 32744979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomics of gliomas: initial biomarker discovery and evolution of technology.
    Kalinina J; Peng J; Ritchie JC; Van Meir EG
    Neuro Oncol; 2011 Sep; 13(9):926-42. PubMed ID: 21852429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrospinal fluid VEGF levels and angiogenic capacity as potential prognostic markers in patients with gliomas: a pilot study.
    Vera S; Sinning M; Vergara M; Lemus D; Rosas C
    J Neurooncol; 2019 Nov; 145(2):233-239. PubMed ID: 31624989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The Present and Future of Less-invasive Liquid Biopsy for the Diagnosis of Gliomas and Brain Tumors].
    Natsumeda M; On J; Watanabe J; Tsukamoto Y; Okada M; Fujii Y; Adachi J; Nishikawa R
    No Shinkei Geka; 2021 May; 49(3):527-534. PubMed ID: 34092558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.